chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I had had 4 doses of Moderna and I would typically have fever and chills that lasted 36 hours. After dose 4 I had some fatigue and body aches. I went to the doctor in June 2022 and doctor drew blood. I was found to have MGUS, Monoclonal Gammopathy of Unknown Significance, an abnormal protein in blood. I was then sent to the oncologist.
Began "hives breakout" at approx. 7:00 pm on 11/19/99, the day of shot. By 8:00 am on 11/20/99, breakout was all over body. Tx'd with Benadryl over-the-counter pills.
every bone in body hurting; chills; headache; This spontaneous case was reported by a consumer and describes the occurrence of BONE PAIN (every bone in body hurting), CHILLS (chills) and HEADACHE (headache) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 010A21A) for COVID-19 vaccination.     Concomitant products included LOVASTATIN, LISINOPRIL, MONTELUKAST, CETIRIZINE, FINASTERIDE, MELOXICAM, PSEUDOEPHEDRINE HYDROCHLORIDE (SUDAFED 12 HOUR), CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000), FISH OIL and VITAMINS;MINERALS;LYSINE for an unknown indication.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Feb-2021, the patient experienced BONE PAIN (every bone in body hurting), CHILLS (chills) and HEADACHE (headache). The patient was treated with PARACETAMOL (TYLENOL) at a dose of twice. At the time of the report, BONE PAIN (every bone in body hurting), CHILLS (chills) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication include AERDS. Patient consumed lots of water along with Tylenol treatment
Patient was administered  a Pfizer 2nd Dose when they had Moderna as a 1st Dose.
Nurse said she was having a problem with the syringe plunger while the needle was already in my left shoulder.  After a few seconds, she finally was able to get the fluid injected.  Immediately I felt a numbing pain in my left shoulder.  A few hours later, I could not lift my left arm above shoulder level and my whole shoulder was very painful, especially the shoulder joints.  On 10/11/2015 I went to Dr. at Immediate Care, because my left arm started getting numb, lame and tingly.  The shoulder was still sore.  She prescribed 3-4 Advils three times per day and and referred me to a neurologist.  Today, 10/21/2015 the pain in my shoulder is still severe and I have limited range of motion.  It seems to be getting worse, rather than better.  I have had 2 physical therapy treatments, which so far have not yet helped.  I have made an appointment to see someone on Monday (10/26/2015) and hope to get an MRI of my shoulder and get referred to an orthopedic surgeon.
I had an upper respiratory infection that included a lot of malaise for two months.  This began in October 2022 with a productive cough.  I visited the doctor and received no treatment and diagnosed with upper respiratory virus.  Now, I am having symptoms again with shortness of breath but no cough.  I am being treated with Lasix.
DTaP by Infanrix lot # A573B9 in Lt. deltoid admin. 04/25.  Also in Lt arm IPV Lot # U0347 Sub -Q 04/25.  Presented to clinic on 04/28 after 4cmx5cm area on Lt arm below injection site of erythematous, warm to touch, and hardened.  No pain.
vax administered 23OCT92-ER visit w/febrile seizure 23OCT92 late PM; t104.7;
Left sided facial redness, itching and swelling 1 day after vaccine administered into left deltoid. Also felt lightheaded day of vaccine.
pt recv vax 5SEP96 & 30APR(7 pt devel about 30 lesions & a fever of 102;
Tremors. I received the Pfizer booster shoot which caused serious swelling in my left arm. The same week, I began to experience tremors in both of my hands and limb weakness in the left arm, which is the arm that I received the injection in.
Extreme soreness at injection site starting a couple of hours after injection (unable to lay on left side, put pressure on injection site).  Lasted for three days.  Itchiness at injection site 2 days after injection, lasted two days.  13 days after injection, 2 inch welt with darker red ring formed at injection site, site is itchy again.  Did not do any treatment except for putting steroid creme on site today.  Helped with itching.
Systemic: Dizziness / Lightheadness-Medium, Additional Details: Patient said they felt light headed. We had her lay down. First blood pressure was low  80/64, then 99/64,  after sitting went to 110/69 with pulse of 55 which patient and parent said was normal. Patient was feeling good upon leaving. Note, patient said they had a very light breakfast and might have been a factor.
High fever, chickenpox outbreak on leg, golf ball size cyst that stayed for 3 months, total cessation of speech. Lost all words. No more babbling sounds. It sounded like garbled slurring.
Chills, Fever of 102.7, Fatigue, Pain in full left side of body from injection site down my leg and across to left breast, numbness in left leg, metallic taste in mouth, loss of appetite, chest pain, severe headache. All symptoms last 3 days. On the fourth day the only symptoms that I still had were severe headache and fatigue. By the fifth day, I was able to relieve headache with Tylenol and began to feel better. Tylenol had not helped the first four days.
Pt. called 10-20-06 4:15pm stating that her arm was hurting and that she was experiencing some "chills" last night and today.  She was taking pain medication Percocet 7.5/325 for another pain condition for her back that she used.
TESTED POSITIVE FOR VIRUS; A spontaneous report has been received from a consumer. The report concerns a patient of unknown gender of Unknown ethnic origin (age 5 years).    No medical history was reported.     No concomitant products were reported.    The patient received Flumist Quadrivalent (influenza virus vaccine live, intranasal) (batch number NR) 0.2 ml once/single administration, via nasal route, on an unknown date.     On an unknown date, the patient experienced tested positive for virus (preferred term: Influenza virus test positive).     Treatment with Flumist Quadrivalent (influenza virus vaccine live, intranasal) was not changed.     The outcome of the event was unknown.    The event was considered non-serious.
PATIENT MOM CALLED AND SAID AFTER ABOUT 2 HOURS POST VACCINE ALL 10 FINGERS WERE NUMB
Edema, warm, and sore to upper arm and elbow area. Today 12/11/2020 it is down to forearm.
Hurts all the body; not been able to recover my arm hurts; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of general body pain in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   In JUN-2023, the patient received the 1st dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced general body pain (Verbatim: Hurts all the body) and pain in arm (Verbatim: not been able to recover my arm hurts). The outcome of the general body pain and pain in arm were not resolved.   It was unknown if the reporter considered the general body pain and pain in arm to be related to Shingles vaccine.     It was unknown if the company considered the general body pain and pain in arm to be related to Shingles vaccine.   Additional Information: GSK receipt date: 22-Jul-2023 This case was reported by the patient via interactive digital media. The patient stated that he/she did not know which was more painful, that or the vaccination, he/she got vaccinated a month ago from reporting and it was horrible. The patient not recovered yet, arm hurts and full body hurts. The patient stated that he/she did not though that he/ she would get the 2nd dose, it was killing him/ her, goodness knew what they were did with the patient and he/she did not know if the person who vaccinated had heavy hand, or they touched the bone. The patient stated that the truth was that the vaccine did not went well, so he/she certainly did not recommend it.
Employee reports pain and decreased mobility in R arm and shoulder. Pain is intermittent and increases when raising arm over head.
itching; I broke out in welts around the injection site; I broke out in a rash around the injection site; This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itching), VACCINATION SITE URTICARIA (I broke out in welts around the injection site) and VACCINATION SITE RASH (I broke out in a rash around the injection site) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure raised, Diabetes and Restless legs.    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Jan-2021, the patient experienced PRURITUS (itching), VACCINATION SITE URTICARIA (I broke out in welts around the injection site) and VACCINATION SITE RASH (I broke out in a rash around the injection site). At the time of the report, PRURITUS (itching), VACCINATION SITE URTICARIA (I broke out in welts around the injection site) and VACCINATION SITE RASH (I broke out in a rash around the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications included unspecified medication for blood pressure, diabetes and restless legs were noted. Treatment information was not provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 27-Jul-2021: Follow up received included no new information was provided.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Severe rash, soreness from elbow to shoulder (L). Same as injection site. Treated with hydrocortisone cream 1% OTC.
Systemic: Seizure-Severe, Additional Details: around 5:30pm patient was sitting after her covid vaccine.  patient fell face first to the ground and begin to have a seizure.  911 was called and patient was taken to the hospital.  Before leaving patient's vitals were back to normal, but was taken to the hospital for obseravation.  RPh, and ARNP were performing immunizations at the time.
Pt had urticarial rash over entire body. No trouble breathing. Given oral Benadryl with alleviation of some symptoms.
No adverse effects reported; MMRII and VARIVAX administered to patient after TE occurred.; This spontaneous report was received from a medical assistant and referred to a 4-year-old patient of unknown gender. The patient's medical history, concurrent conditions, and concomitant therapies were not reported.  On 22-MAY-2023, the patient vaccinated with improperly stored measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) injection (lot# was reported as U39664, expiration date was reported as 15-DEC-2023, therapy type, strength, dose, frequency, and route were unknown) and varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection(lot #W011625, expiration date: 06-APR-2024, strength, dose, frequency, and route were unknown) for prophylaxis(Product storage error). No adverse effect was reported.  The stored temperature was 73 Fahrenheit (F). The time frame was 51 hours and 30 minutes. There was no previous temperature excursion.  Lot Number U39664 was not valid for measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (M-M-R II) and did not match any Company product.  This is one of several reports from the same reporter.; Sender's Comments:  US-009507513-2305USA008345: US-009507513-2305USA008288: US-009507513-2305USA008329:
VACCINE WAS ADMINISTERED ON MARCH 23 AND THE FOLLOWING MONDAY MARCH 29TH I was diagnosed with Shingles
everything began to swim in front of her/Felt her knees giving out. Woke up face down on floor.; BP it was quite high; Blood began to drip from head wound.; blood began to drip from head wound; limbs felt rubbery and out of sorts; This is a spontaneous report from a contactable consumer (patient). A 69-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration, administered in arm right on 24Mar2021 at 08:30 (Lot Number: ER8732) (at the age of 69-year-old) as single dose for COVID-19 immunisation. The patient was not pregnant. The patient not tested positive to COVID-19 pre or post vaccination. The patient medical history was not reported. Concomitant medications included amlodipine; fluoxetine; metoprolol and omeprazole, all concomitants were taken for an unspecified indication, start and stop date were not reported.  The patient reported that on 24Mar2021 at 9:15 everything began to swim in front of her, the sink, counter, coffee pot, etc. Grabbed edge of sink to steady herself. Felt her knees giving out. Woke up face down on floor. Her limbs felt rubbery and out of sorts. Blood began to drip from head wound. Grabbed counter edge and pulled herself upright. Grabbed paper towel for compress. Wobbled over to sofa. She laid down. Her husband came home measured her blood pressure (BP) it was quite high and would not go down. She went to ER immediately. At ER, they took blood, observed, did Echo on heart and sent her home. No therapeutic measures were taken as a result of the events. The patient outcome of the events was recovered.
Patient is here for evaluation of dizziness and symptoms that she thinks may be related temporally to the injection of a TDAP that was given on 4/14/09.  Immediately that evening, patient did note headache.  Normally she doesn't get headaches, but this seemed to be over the entire head.  She did use some ibuprofen and went to bed.  She did notice that she had a faint headache the following day, but it seemed to have subsided.  She noted today, however, that when she moved her eyes to the right she felt that she had some tingling in her lower legs.  She has not been seeing double at all, but she had a hard time focusing with the right eye.  That seems to have resolved completely without any symptoms at this point.  She notes that she has had a history of multiple sclerosis and that has been stable for many years.  She did have interferon in the past with her neurologist, but has not had any weakness in the lower extremities or urinary symptoms or visual symptoms that she initially started out with when she was first diagnosed with the multiple sclerosis many years ago.  She is not on any type of treatment for that.  In addition, she notes that she feels somewhat dizzy, head in the cloud sensation, but not spinney sensation and not the sensation of fainting.  When she is lying in bed and getting up, she doesn't feel particularly dizzy; however, if she is sitting and then moves her head in certain positions and then turns her eyes, she will get those associated vibratory sensations in the lower extremities.  It seems to be getting better, however, but is here for documentation.  Patient also is here to reevaluate her blood work results.  These are discussed with her.  Her cholesterol profile is much better on the omega-3.  She just started also LOVASA, and looking up the adverse reactions to this, there are no neurological side effects.  In fact, looking up the side effects of the TDAP, there is no direct causal relationship with the type of symptoms this patient is having although mention of a neuritis and demyelinization has been made without definitive causal relationships.  Alert and oriented.  Fundoscopic difficult to see, but the part that is seen shows the disks to be flat.  AV ratio is 1:2 bilaterally. PERRLA.  EOM intact.  There is no hyphema.  There is no diplopia.  Visual fields arm normal by confrontation.  Pharynx is clear.  TMs normal.  Neck-Full range of motion.  Neurological - Cranial nerves II-XII grossly normal and DTRs are 3/4 equally bilaterally upper and lower extremities.  Otherwise, neurologically, her gait is normal.  She is not dizzy, and she has a negative hill-pike maneuver.  Symptoms may be Side effects of a TDAP Inoculation in a patient with Underlying but Stable Multiple Sclerosis.  Since these are getting better, will watch them for now, but if things get worse and she has localizing symptoms, then will refer her to her neurologist, for further evaluation and / or workup or treatment.
This spontaneous report as received from a medical assistant refers to an unspecified number of patients of unknown age and gender. No information regarding the patients' medical history or concurrent conditions was provided. On unknown dates in May 2016, reported as starting on or after 05-MAY-2016, the patients were vaccinated with improperly stored doses of VAQTA injection (dose, route of administration, lot# and expiry date were not reported). There were no concomitant therapies reported. The call was made because of a data logger. The reporter stated that the doses of the vaccine were exposed to a temperature of 1.4 degrees Celsius for a time frame of 138 hours. The vaccine was not exposed to any previous temperature excursions. No adverse effects were reported. There was no product quality complaint involved. This is one of several reports received from the same reporter. Additional information has been requested.
BLOOD CLOTS; This spontaneous report received from a consumer via other company (Pfizer, report number: 2021503212) concerned multiple patients of unspecified age and sex. Patient's height, and weight were not reported. No past medical history or concurrent conditions were reported.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The batch number was not reported. Per procedure, no follow up will be requested for this case. No concomitant medications were reported.  On an unspecified date, reporter stated that patients experienced blood clots that scared people all the way around (no further information provided or obtained). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of blood clots was not reported. This report was serious (Other Medically Important Condition).; Sender's Comments: V0 : 20210547337 - COVID-19 VACCINE AD26.COV2.S-Blood clots. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).
CoVid -19 vaccine given at 1 pm.  At 1:15 pm patient calling for help.  Assisted by staff.  Symptoms reported  "tongue feel little tingling."  Given Benadryl 25 mg p.o..  No difficulty swallowing,  No difficulty breathing,  No rashes or any symptoms presented.  Immediate relief felt after being observed for 5 min.    Stated " imagining thing"  "nervous"  "completely normal now."
Expired vaccine received; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine received) in an 83-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 009C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 11-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .5 milliliter. On 06-Dec-2021 at 4:14 PM, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .25 milliliter. On 06-Dec-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine received). On 06-Dec-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine received) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications information was reported. No treatment medications were provided.  After receiving the booster dose of Moderna COVID-19 Vaccine, the patient did not have any immediate issues and had not contacted to notify of any adverse reactions/events.   This case was linked to MOD-2021-407228 (Patient Link).
Moderna COVID-19 EUA 1/19/21 Slightly sore arm by about 9:30 pm on the day of the shot. 1/20/21 Next morning, about 7:00 am, very sore arm - unable to raise right arm above horizontal without extreme pain. Alos, about noon, felt exhausted, had a 100 degree fever, and felt like chills were coming on. 1/21/21 About 7:00 am, sore arm, but can raise it about 45 degrees above horizontal. Still tired but no fever or chills. By the afternoon, about 3:00 pm, felt completely well except for a sore arm. 1/22/21 About 7:00 am, sore arm, but can raise it to vertical, with difficulty. Feel well otherwise. 1/23/21 Arm back to normal.
Very irritable within 1 1/2 of vaccines and continued for several hours. Pt with onset viral upper respiratory illness 3 days after vaccines.
Initial case received from a health care professional on 16 December 2009. An 8-year-old female patient received an influenza vaccine reported as possibly FLUZONE (lot not reported) on 12 November 2001. The patient had a history of asthma and an allergy to CECLOR, and was taking Albuterol concomitantly. At the time of vaccination she had a sore throat and congestion. The day after vaccination, on 13 November 2009, she developed a generalized rash, itching, hives and swollen feet lasting 1/2 of the day. The reporter was unsure if the influenza vaccine was FLUZONE. Documents held by sender: None.
diagnosed with COVID; diagnosed with COVID; This is a spontaneous report received from a contactable reporter (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 78-year-old female patient received bnt162b2 (PFIZER COVID-19 VACCINE) (Lot number: unknown) as dose number unknown (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (dose number unknown, MANUFACTURER UNKNOWN), for Covid-19 immunization. The following information was reported: DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant), outcome "unknown" and all described as "diagnosed with COVID". Clinical course: Caller mentioned to have received COVID-19 vaccine and booster dose (no brand name), but reported being diagnosed with COVID prior to starting Paxlovid treatment. Caller was in current treatment with Paxlovid, stating she's "almost finished" and only one day left for treatment. Caller reported an "overwhelming bitter taste that didn't go away", then described it as "toilet water and metal taste, it was so incredibly bitter that I can only describe it as bile taste". Reporter's seriousness criteria was non-serious. She wanted to know if this had been reported, if she can take any medication to get rid of the bad taste and if it will be "residual" or for how long will it last after treatment. Caller wanted to know if Paxlovid was "made" for treatment of "COVID-19 Omicron variant" or for "COVID-19 in general". Caller wanted to know if Paxlovid was already approved or if it was still under EUA.  The lot number for bnt162b2 was not provided and will be requested during follow up.
Patient complained of numbness in right hand and arm about 20 minutes after dose was given. Shortly after she began complaining of tightness in the chest and ringing in the ears. She was given benadryl and monitored. She complained of being hot and was given an ice pack. She stayed for 1 hour and 30 minutes under supervision. When she left she was not symptomatic and was accompanied by her spouse.
Left arm: 6cm area of erythema to lateral portion - laterally raised, starting approximately 1/3 of the way down the arm, significantly warmer to the touch - indurated & mildly tender.